Pain Therapeutics Inc (NASDAQ:PTIE)

1.80
Data as of Nov 21
 +0.13 / +7.78%
Today’s Change
1.61
Today|||52-Week Range
6.22
-62.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$82.4M

Company Description

Pain Therapeutics, Inc. is a biopharmaceutical company, which develops novel drugs. The company is developing a novel drug candidate to treat metastatic melanoma, a deadly form of skin cancer. It has four drug candidates in clinical program, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.

Contact Information

Pain Therapeutics, Inc.
7801 North Capital of Texas Highway
Austin Texas 78731
P:(512) 501-2444
Investor Relations:

Employees

Shareholders

Other institutional53.89%
Individual stakeholders32.37%
Mutual fund holders14.75%

Top Executives

Remi BarbierChairman, President & Chief Executive Officer
Nadav FriedmannDirector, Chief Operating & Medical Officer
Peter S. RoddyChief Financial Officer & Vice President
George ThorntonSenior Vice President-Technology
Michael J. O'DonnellSecretary & Independent Director

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.